BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 617072)

  • 1. Prevention and suppression of post-partum lactation with 2-bromo-alpha-ergocryptine (CB-154).
    Macleod SC; Scott J; Lord L; Brodie G; Perlin I; Simpson AA
    Clin Endocrinol (Oxf); 1977; 6 Suppl():65S-70S. PubMed ID: 617072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation.
    Walker S; Groom G; Davis RH; Hibbard BM; Griffiths K
    Lancet; 1975 Nov; 2(7940):842-4. PubMed ID: 53330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum prolactin and the suppression of lactation.
    Weinstein D; Ben-David M; Polishuk WZ
    Br J Obstet Gynaecol; 1976 Sep; 83(9):679-82. PubMed ID: 788774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ; 1991 Jun; 302(6789):1367-71. PubMed ID: 1676318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation [proceedings].
    Walker S
    Br J Clin Pharmacol; 1975 Aug; 2(4):368P-369P. PubMed ID: 788734
    [No Abstract]   [Full Text] [Related]  

  • 6. [Puerperal inhibition of lactation with metergoline or bromocriptine].
    Fischer T; Streitmatter A; Gerede A; Frauendorf A; Krause M; Feige A
    Z Geburtshilfe Neonatol; 1995; 199(3):111-5. PubMed ID: 7553254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study.
    Utian WH; Begg G; Vinik AI; Paul M; Shuman L
    Br J Obstet Gynaecol; 1975 Sep; 82(9):755-9. PubMed ID: 1101946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of puerperal lactation: evaluation of bromocriptine and placebo.
    Bhardwaj N
    Aust N Z J Obstet Gynaecol; 1979 Aug; 19(3):154-7. PubMed ID: 391210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactation inhibition by a single injection of a new depot-bromocriptine.
    Kremer JA; Rolland R; van der Heijden PF; Schellekens LA; Vosmar MB; Lancranjan I
    Br J Obstet Gynaecol; 1990 Jun; 97(6):527-32. PubMed ID: 2378830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C; Leke R
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of puerperal lactation. A double blind study of bromocriptine and placebo.
    Dewhurst CJ; Harrison RF; Biswas S
    Acta Obstet Gynecol Scand; 1977; 56(4):327-31. PubMed ID: 341635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of puerperal lactation by bromocriptine.
    Rolland R; Schellekens LA
    Acta Endocrinol Suppl (Copenh); 1978; 216():119-30. PubMed ID: 347857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of puerperal lactation using jasmine flowers (Jasminum sambac).
    Shrivastav P; George K; Balasubramaniam N; Jasper MP; Thomas M; Kanagasabhapathy AS
    Aust N Z J Obstet Gynaecol; 1988 Feb; 28(1):68-71. PubMed ID: 3214386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of lactation with 2-bromo-alpha-ergocryptine (CB-154)].
    Solla E; Murru S; Onano AM; Melis GB
    Ann Ostet Ginecol Med Perinat; 1978; 99(3):199-207. PubMed ID: 677680
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of lactation by a long-acting bromocriptine.
    Peters F; Del Pozo E; Conti A; Breckwoldt M
    Obstet Gynecol; 1986 Jan; 67(1):82-5. PubMed ID: 3940343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suppression of puerperal lactation with bromocryptine.
    Willmott MP; Colhoun EM; Bolton AE
    Acta Obstet Gynecol Scand; 1977; 56(2):145-9. PubMed ID: 324230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression by bromocriptine of the serum lactalbumin peak associated with human lactogenesis.
    Martin RH; Glass MR; Chapman C; Wilson GD; Woods KL
    Clin Endocrinol (Oxf); 1981 Apr; 14(4):363-6. PubMed ID: 7261418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ; Josimovich JB; Archer DF
    Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.